Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 113351-113400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04439175
Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)
PHASE2Active, not recruiting
70 participants
Started: Feb 25, 2016 · Completed: Mar 19, 2026
6 conditions1 sponsor1 location
NCT02842424
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
PHASE4Recruiting
70 participants
Started: Feb 25, 2016 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04439357
Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)
PHASE2Active, not recruiting
4 participants
Started: Feb 25, 2016 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT04439318
Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)
PHASE2Active, not recruiting
50 participants
Started: Feb 25, 2016 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT04439149
Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)
PHASE2Active, not recruiting
24 participants
Started: Feb 25, 2016 · Completed: Nov 30, 2025
6 conditions1 sponsor1 location
NCT02713334
Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling
N/AActive, not recruiting
495 participants
Started: Feb 25, 2016 · Completed: Feb 25, 2026
1 condition1 sponsor1 location
NCT02710734
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
PHASE2Active, not recruiting
78 participants
Started: Feb 24, 2016 · Completed: Feb 28, 2034
1 condition1 sponsor4 locations
NCT06357988
Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)
PHASE2Active, not recruiting
35 participants
Started: Feb 24, 2016 · Completed: Dec 31, 2026
6 conditions1 sponsor1 location
NCT02478099
MPDL3280A-treatment-IST-UMCG
PHASE2Active, not recruiting
81 participants
Started: Feb 24, 2016 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT02453984
MPDL3280A-imaging-IST-UMCG
NAActive, not recruiting
45 participants
Started: Feb 24, 2016 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT02571725
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Feb 23, 2016 · Completed: Jul 15, 2027
3 conditions1 sponsor5 locations
NCT02734290
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
PHASE1/PHASE2Active, not recruiting
29 participants
Started: Feb 23, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05169333
The Oxford Risk Factors And Non-Invasive Imaging Study
N/ARecruiting
250,000 participants
Started: Feb 23, 2016 · Completed: Feb 28, 2030
2 conditions7 sponsors37 locations
NCT05049746
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
NAActive, not recruiting
95 participants
Started: Feb 23, 2016 · Completed: Feb 2, 2027
20 conditions1 sponsor1 location
NCT02671435
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
PHASE1/PHASE2Active, not recruiting
383 participants
Started: Feb 22, 2016 · Completed: Sep 1, 2025
1 condition1 sponsor49 locations
NCT02406729
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
PHASE3Active, not recruiting
16,935 participants
Started: Feb 22, 2016 · Completed: Nov 30, 2024
1 condition1 sponsor17 locations
NCT02611089
Muscle Connective Tissue in Limb Development and Disease
N/ARecruiting
150 participants
Started: Feb 20, 2016 · Completed: Aug 31, 2036
1 condition4 sponsors5 locations
NCT02689440
Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
PHASE2Active, not recruiting
155 participants
Started: Feb 19, 2016 · Completed: Dec 31, 2040
2 conditions2 sponsors1 location
NCT04268901
VR to Reduce Pain/Anxiety During Painful Procedures
NARecruiting
700 participants
Started: Feb 19, 2016 · Completed: Dec 6, 2025
8 conditions2 sponsors1 location
NCT06596265
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
N/ARecruiting
1,000 participants
Started: Feb 17, 2016 · Completed: Jun 17, 2028
6 conditions3 sponsors1 location
NCT05386615
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
N/ARecruiting
200 participants
Started: Feb 16, 2016 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT03430492
Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience
N/AActive, not recruiting
985 participants
Started: Feb 15, 2016 · Completed: Dec 31, 2025
1 condition5 sponsors4 locations
NCT02626312
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
PHASE1Active, not recruiting
36 participants
Started: Feb 15, 2016 · Completed: Apr 28, 2026
4 conditions2 sponsors1 location
NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
PHASE1Recruiting
22 participants
Started: Feb 12, 2016 · Completed: Dec 31, 2027
11 conditions1 sponsor1 location
NCT02453620
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
PHASE1Active, not recruiting
57 participants
Started: Feb 12, 2016 · Completed: Sep 17, 2026
5 conditions1 sponsor5 locations
NCT02625961
Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
PHASE2Active, not recruiting
320 participants
Started: Feb 10, 2016 · Completed: Oct 31, 2025
1 condition1 sponsor0 locations
NCT02610673
WiCS-LV Post Market Surveillance Registry
N/AActive, not recruiting
100 participants
Started: Feb 8, 2016 · Completed: Jun 30, 2027
1 condition1 sponsor3 locations
NCT03934957
Hamburg City Health Study - a German Cohort Study
N/ARecruiting
45,000 participants
Started: Feb 8, 2016 · Completed: Dec 31, 2028
10 conditions3 sponsors1 location
NCT02649387
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy
PHASE2Active, not recruiting
35 participants
Started: Feb 8, 2016 · Completed: Jan 15, 2026
4 conditions1 sponsor1 location
NCT03386981
Metabolic Profile of Bone in Professional Athletes
N/ARecruiting
200 participants
Started: Feb 4, 2016 · Completed: Feb 4, 2027
2 conditions1 sponsor1 location
NCT02659241
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
EARLY_PHASE1Active, not recruiting
38 participants
Started: Feb 4, 2016 · Completed: Dec 31, 2026
22 conditions2 sponsors8 locations
NCT03670472
Correction of Nonsense Mutations in Cystic Fibrosis
N/ARecruiting
85 participants
Started: Feb 3, 2016 · Completed: Jan 31, 2030
1 condition2 sponsors8 locations
NCT03905668
Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future: Intelligent ICU of the Future
N/AActive, not recruiting
71 participants
Started: Feb 3, 2016 · Completed: Jul 31, 2028
2 conditions5 sponsors1 location
NCT02701153
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
NARecruiting
51 participants
Started: Feb 3, 2016 · Completed: Feb 3, 2027
1 condition5 sponsors1 location
NCT02861781
Collection of Human Metabolic Tissues
N/ARecruiting
270 participants
Started: Feb 2, 2016 · Completed: Sep 30, 2028
3 conditions1 sponsor1 location
NCT02736656
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
PHASE3Active, not recruiting
1,400 participants
Started: Feb 2, 2016 · Completed: Sep 30, 2026
1 condition1 sponsor16 locations
NCT02381561
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
PHASE1Active, not recruiting
19 participants
Started: Feb 1, 2016 · Completed: Mar 14, 2026
41 conditions1 sponsor1 location
NCT03444259
Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients
N/AActive, not recruiting
1,001 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2029
8 conditions2 sponsors1 location
NCT02662907
Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy
NAActive, not recruiting
175 participants
Started: Feb 1, 2016 · Completed: Feb 2, 2027
1 condition2 sponsors1 location
NCT06830590
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
N/ARecruiting
300 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT02625480
Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
95 participants
Started: Feb 1, 2016 · Completed: Feb 28, 2026
2 conditions1 sponsor30 locations
NCT03256201
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes
NAActive, not recruiting
95 participants
Started: Feb 1, 2016 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT03057860
TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
N/ARecruiting
2,800 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT06648044
Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies
NARecruiting
310 participants
Started: Feb 1, 2016 · Completed: Feb 1, 2028
7 conditions1 sponsor1 location
NCT04571177
PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke
N/AActive, not recruiting
20 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03521921
GIse Registry Of Transcatheter Treatment of Mitral Valve regurgitaTiOn (GIOTTO)
N/AActive, not recruiting
1,500 participants
Started: Feb 1, 2016 · Completed: Sep 9, 2025
1 condition1 sponsor20 locations
NCT02849132
Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients
PHASE4Active, not recruiting
800 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2025
2 conditions8 sponsors20 locations
NCT02730338
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
NAActive, not recruiting
866 participants
Started: Jan 31, 2016 · Completed: Oct 31, 2026
1 condition5 sponsors18 locations
NCT02509286
Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
PHASE3Active, not recruiting
438 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2024
2 conditions6 sponsors30 locations
NCT03033771
Dragon Study Europe
NAActive, not recruiting
27 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2029
1 condition1 sponsor4 locations